Horne William B. 4
4 · Alzamend Neuro, Inc. · Filed Jan 25, 2022
Insider Transaction Report
Form 4
Horne William B
Director
Transactions
- Exercise/Conversion
Stock Options (Right to Buy)
2022-01-24−150,000→ 2,250,000 totalExercise: $0.00Exp: 2026-04-29→ Common Stock (150,000 underlying) - Exercise/Conversion
Common Stock
2022-01-24$0.00/sh+150,000$600→ 250,000 total
Holdings
- 250,000
Stock Options (Right to Buy)
Exercise: $1.50Exp: 2029-11-25→ Common Stock (250,000 underlying) - 250,000
Stock Options (Right to Buy)
Exercise: $1.50Exp: 2029-11-25→ Common Stock (250,000 underlying)
Footnotes (4)
- [F1]This transaction was effected pursuant to Rule 16b-3 with shares of common stock received upon the exercise of stock options.
- [F2]The stock options exercised in this transaction were fully vested and exercisable as of the transaction date.
- [F3]The stock options vest ratably over thirty-six (36) months beginning on the date of grant.
- [F4]None of these performance-based stock options are vested or exercisable.